Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
{{output}}
Background: Treatment of chronic lymphocytic leukemia (CLL) currently consists of two main approaches - continuous therapy with Bruton's tyrosine kinase inhibitors and fixed-duration regimens combining venetoclax with either CD2... ...
